Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

R. Donders

2 papers in the library · publishing 2015-2018

Papers

Face-to-Face and Internet-Based Mindfulness-Based Cognitive Therapy Compared With Treatment as Usual in Reducing Psychological Distress in Patients With Cancer: A Multicenter Randomized Controlled Trial.

Journal of Clinical Oncology June 28, 2018 F. Compen, E. Bisseling, M. Schellekens et al.

Mindfulness-based cognitive therapy (MBCT) and an individual internet-based version (eMBCT) both reduced psychological distress in cancer patients more than treatment as usual (TAU). In a randomized trial of 245 distressed cancer patients, those receiving MBCT or eMBCT reported significantly less distress post-intervention (Cohen's d = .45 and .71, respectively). Both interventions also reduced fear of cancer recurrence and rumination, and improved mental health-related quality of life, mindfulness skills, and positive mental health compared to TAU. Physical health-related quality of life did not improve. Post-treatment psychiatric diagnosis prevalence was lower with MBCT (33% improvement) and eMBCT (29% improvement) versus TAU (16%), but these differences were not statistically significant.

A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol

BMC Psychiatry November 9, 2015 M. Cladder-Micus, J. Vrijsen, E. Becker et al.

A randomized controlled trial will compare Mindfulness-Based Cognitive Therapy (MBCT) plus treatment-as-usual (TAU) against TAU alone for patients with chronic, treatment-resistant depression who have already received antidepressant medication and either cognitive behavioral therapy or interpersonal therapy. The primary outcome is depressive symptoms; secondary outcomes include remission rates, quality of life, rumination, mindfulness skills, and self-compassion. Assessments occur at baseline and after the intervention or TAU period, with follow-up at three and six months post-MBCT for completers. The trial aims to provide information on MBCT's effectiveness in this population.